Literature DB >> 15105265

Oxidative stress and redox-active iron in Alzheimer's disease.

Kazuhiro Honda1, Gemma Casadesus, Robert B Petersen, George Perry, Mark A Smith.   

Abstract

Many lines of evidence indicate that oxidative stress is one of the earliest events in the genesis of Alzheimer's disease (AD). Iron is a transition metal capable of generating hydroxyl radicals, the most potent reactive oxygen species. Consequently, a disruption in the metabolism of iron has been postulated to have a role in the pathogenesis of AD. Indeed, both senile plaques and neurofibrillary tangles, the major pathological landmarks of AD, as well as neurons in the earliest stages of the disease, show elevated iron deposition. However, it is clear that the iron bound to lesion-associated proteins such as amyloid-beta and tau plays only a minor, late role in the disease, with the RNA-associated iron found in the neuronal cytoplasm occurring early and being of paramount importance. In this regard, it is probably not surprising that there is significant oxidation of cytoplasmic RNA among the populations of neurons vulnerable to AD. In this review, we consider the role of iron-induced oxidative stress as a key event in AD pathophysiology.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15105265     DOI: 10.1196/annals.1306.015

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  46 in total

1.  Minimal peroxide exposure of neuronal cells induces multifaceted adaptive responses.

Authors:  Wayne Chadwick; Yu Zhou; Sung-Soo Park; Liyun Wang; Nicholas Mitchell; Matthew D Stone; Kevin G Becker; Bronwen Martin; Stuart Maudsley
Journal:  PLoS One       Date:  2010-12-17       Impact factor: 3.240

2.  Unraveling the role of metal ions and low catalytic activity of cytochrome C oxidase in Alzheimer's disease.

Authors:  Trevor Alleyne; Neetu Mohan; Jerome Joseph; Andrew Adogwa
Journal:  J Mol Neurosci       Date:  2010-08-20       Impact factor: 3.444

3.  Fruit and vegetable juices and Alzheimer's disease: the Kame Project.

Authors:  Qi Dai; Amy R Borenstein; Yougui Wu; James C Jackson; Eric B Larson
Journal:  Am J Med       Date:  2006-09       Impact factor: 4.965

4.  Longitudinal study of differential protein expression in an Alzheimer's mouse model lacking inducible nitric oxide synthase.

Authors:  Michael D Hoos; Brenna M Richardson; Matthew W Foster; Angela Everhart; J Will Thompson; M Arthur Moseley; Carol A Colton
Journal:  J Proteome Res       Date:  2013-09-18       Impact factor: 4.466

Review 5.  Novel therapeutics for Alzheimer's disease: an update.

Authors:  David J Bonda; Hyun-Pil Lee; Hyoung-gon Lee; Avi L Friedlich; George Perry; Xiongwei Zhu; Mark A Smith
Journal:  Curr Opin Drug Discov Devel       Date:  2010-03

6.  Brain catalase in the streptozotocin-rat model of sporadic Alzheimer's disease treated with the iron chelator-monoamine oxidase inhibitor, M30.

Authors:  E Sofic; M Salkovic-Petrisic; I Tahirovic; A Sapcanin; S Mandel; M Youdim; P Riederer
Journal:  J Neural Transm (Vienna)       Date:  2014-09-25       Impact factor: 3.575

7.  Neuroprotection against iron-induced cell death by perineuronal nets - an in vivo analysis of oxidative stress.

Authors:  Anne Suttkus; Susanne Rohn; Carsten Jäger; Thomas Arendt; Markus Morawski
Journal:  Am J Neurodegener Dis       Date:  2012-07-23

8.  Association between food and nutrient intakes and cognitive capacity in a group of institutionalized elderly people.

Authors:  Aránzazu Aparicio Vizuete; Francisco Robles; Elena Rodríguez-Rodríguez; Ana María López-Sobaler; Rosa María Ortega
Journal:  Eur J Nutr       Date:  2009-12-15       Impact factor: 5.614

9.  Arsenic trioxide induces apoptosis in human colorectal adenocarcinoma HT-29 cells through ROS.

Authors:  Young Cha; Dae-Weon Park; Chu Hee Lee; Suk-Hwan Baek; Seong-Yong Kim; Jae-Ryong Kim; Jung Hye Kim
Journal:  Cancer Res Treat       Date:  2006-02-28       Impact factor: 4.679

10.  Cellular and biochemical actions of melatonin which protect against free radicals: role in neurodegenerative disorders.

Authors:  Genaro G Ortiz; Gloria A Benítez-King; Sergio A Rosales-Corral; Fermín P Pacheco-Moisés; Irma E Velázquez-Brizuela
Journal:  Curr Neuropharmacol       Date:  2008-09       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.